How Medtech Founders Should Prepare for LSI Europe Before the Conference Begins

For every medtech founder heading into LSI Europe, learning how to prepare for the LSI medtech conference is different from prepping for any single investor meeting. LSI Europe runs September 28 to October 1 in Barcelona. It concentrates the medtech founders and investors you most want to reach into four days.

Which is exactly why LSI conference medtech operators who show up unprepared burn more opportunity in one week than they'd burn in six months of ordinary fundraising.

Great companies don't wait for markets to form. They shape the room before they walk into it. LSI Europe is the room where that discipline is most obvious.

Over 370-plus episodes of State of MedTech, the pattern is consistent. Founders walk into LSI with a packed calendar and a rehearsed pitch, and most of them are already behind before the first meeting starts.

The companies that leave LSI with real investor momentum did the work in the weeks before, not during the four days on site.

Takeaways

• Learning how to prepare for the LSI medtech conference is a market engineering exercise, not a meeting prep exercise. The founders who leave LSI Europe with investor momentum did the work weeks and months before the show floor opened.
• Chamath's line on the show applies directly: the deal didn't close in the deal room, and LSI Europe works the same way. The deal closes in the market engineering you did before you booked the flight.
• LSI Europe is widely regarded among medtech investors as the top conference to attend when raising capital. That raises the stakes on every meeting you book there.
• Attend LSI from a position of strength. The dynamic in the room changes when the founder isn't chasing the round to close that week.
• Preparation, structured pre-meeting research, and disciplined post-meeting follow-up separate companies that convert LSI meetings into term sheets from medtech leaders who don't.

Why the Deal Closes Before the Room and Chamath Called It Years Ago

Chamath made this point in an episode about attention as the operating system of AI, media, and markets:

"The deal didn't close in the deal room. The market was shaped years before. And that's what we do. We take the playbooks that built billion-dollar winners in AI, enterprise SaaS, and B2B, and then run them in medtech where almost no one else does."

That's the whole game for LSI Europe.

The investors you want to meet at LSI already have their read on the medtech market before they land in Barcelona. They've been watching who's publishing, who's shaping the category conversation, and who keeps showing up on their podcast queue.

By the time you sit across the table from them at LSI, the read is either already in your favor or it isn't. The pitch is downstream of the market engineering. It's not a substitute for it.

Teams that show up at LSI expecting the pitch itself to close the deal are treating the room like it's the market. It isn't.

The market was shaped in the eighteen months before, and LSI is where the momentum you built (or didn't) converts into meetings that turn into term sheets.

LSI Is the Conference That Matters Most for Medtech Fundraising

I interviewed cardiac tech investor and board chairman Ken Nelson on an episode about medtech investing. He was direct about where LSI ranks among fundraising conferences:

"I think LSI and what Scott Pantel and Henry Peck are doing over there is the best conference to go if you're raising capital and fundraising. I think LSI is definitely the top one."

That status is exactly why showing up unprepared costs more at LSI than anywhere else. The investors you want are already there. They're already meeting a dozen other founders that week, and they're already forming a fast read on who's serious.

A mediocre meeting at a smaller regional event gets forgotten. A mediocre meeting at LSI gets remembered, because the investor is comparing you in real time against every other founder they saw that day.

The bar isn't your pitch in isolation. It's your pitch relative to the best pitch they heard an hour earlier. That comparison dynamic means founders can't treat LSI prep the way they'd treat prep for a single one-off meeting.

Every conversation on site is happening inside a competitive set you can't see. The only way to control your position in that set is to be sharper than you'd otherwise think necessary.

Show Up From Strength

I spoke with Carolina Aguilar, CEO of Inbrain Neuroelectronics, on an episode about rewiring the brain with graphene. She described the mindset shift that changes how investor conversations go:

"I want to be there when I need the money but also when I don't need the money so we can have a much more human and mutual exchange on those events."

A founder who walks into LSI needing the round to close that week reads differently than a founder who's building relationships for a round that isn't urgent yet. Investors can tell the difference within minutes, often from body language and pacing before a single financial detail comes up.

Founders should treat LSI as relationship infrastructure, not a single make-or-break funding event. That reframe changes what a good outcome looks like.

A good outcome isn't a term sheet signed on site. It's three or four investors leaving with a clear, accurate picture of the company, ready to pick the relationship back up when the timing lines up on both sides.

Aguilar's point about a "human and mutual exchange" is the part founders under pressure skip first. When every meeting feels like a pitch, the founder comes across as selling. When even one or two meetings feel like a real conversation, those are usually the ones that turn into something later.

This ties back to the traction gap dynamic. Clinical validation ≠ commercial traction, and FDA clearance is the starting line, not the finish line. Investors know the gap is real.

A founder who walks in from strength implicitly signals they've been building through that gap already, rather than showing up at LSI because the runway is short.

Energy and Conviction Read as Investability

That dynamic showed up in an episode about medtech fundraising valuation and investor strategy, describing one of the strongest pitches heard at the conference:

"He delivered I think the greatest most energizing pitch I've ever seen in a long time at LSI. He's the founder... of Claro Surgical and this guy had like the like Steve Jobs level energy on stage."

Clinical data gets a founder into the room. Conviction is what gets remembered afterward.

Investors sit through dozens of technically sound pitches at LSI. The ones that stick are the ones delivered with genuine belief, not the ones with the cleanest slide deck.

Founders preparing for LSI should rehearse the pitch's energy and delivery with the same seriousness they give the slides. That means practicing out loud, in front of another person, more than once, not just reviewing the deck alone the night before.

Rehearsal here doesn't mean performing enthusiasm that isn't real.

The goal is making sure the founder's real conviction, the belief that got them this far, comes through in a three-minute meeting instead of getting flattened by nerves or over-rehearsed talking points.

The market narrative you deliver on stage or across the table has to sound like something you'd say to a friend at dinner, not something you'd deliver at a corporate presentation. That's the delivery bar the Drill Surgeries pitch cleared.

Preparation and Follow-Up Separate the Teams That Convert

I interviewed Justin Jelley on an episode about making President's Club in SaaS. His read on what separates high performers applies directly to LSI meetings:

"The amount of preparation that they put into pre-meetings during meetings post meeting follow-up like the attention to detail in their preparation and follow-up is I think what separates High performers from the others."

Most founders treat the LSI meeting itself as the deliverable. It isn't. The pre-meeting research on who you're sitting across from and the follow-up in the days after are where the actual fundraising work happens.

Pre-meeting research means knowing the fund's stage focus, their existing portfolio, and whether they've backed anything adjacent to your indication before you sit down.

Showing up with that context lets the meeting start at a more advanced point in the conversation instead of re-explaining basics the investor could have looked up themselves.

Post-meeting follow-up is where most founders lose ground they gained on site. A generic "great to meet you" email sent a week later reads as an afterthought.

A specific follow-up that references what was discussed, sent within a day or two, signals the same seriousness that got the meeting booked in the first place.

Preparation and follow-up compound. The pre-meeting research shapes how the meeting itself opens. The follow-up shapes whether the investor prioritizes your name when their next diligence window opens.

Build the Target Investor List Before You Book a Single Meeting

Most founders approach LSI meeting-scheduling backward. They accept whatever meetings the conference platform surfaces or whatever investors reach out first, then try to make each one count.

The better sequence starts weeks earlier. Build a list of the funds whose stage focus, check size, and portfolio fit the round you're raising.

Rank that list before the conference opens, not during it. A founder who walks in with fifteen ranked, researched targets books meetings with intention. A founder who walks in reactive spends the week meeting whoever happened to respond.

That list also has to be realistic about stage fit.

A fund that only writes Series B checks isn't going to move on your Series A pitch no matter how strong the meeting goes, and pursuing that meeting instead of a stage-appropriate one is time spent on a conversation that was never going to convert.

Once the list exists, prioritize warm introductions over cold outreach wherever possible. A brief note from a mutual portfolio founder or an existing investor carries more weight walking into LSI than any cold email will. It also changes the tone of the first five minutes of the meeting itself.

This is where market-product fit matters at the fundraising layer. Market-product fit inside a fundraise means the round you're raising is tuned to the specific stage-and-thesis fit of the investors on your list.

A round pitched at the wrong stage of fund reads as noise, regardless of how strong the underlying company is.

What the Room Looks Like When You've Prepared

The difference between a prepared founder and an unprepared one is visible within the first ninety seconds of a meeting, before either side has said anything about the technology.

A prepared founder opens with something specific to that investor: a reference to their portfolio, their stated thesis, or a mutual connection. An unprepared founder opens with the same generic pitch they'd give anyone in the room, which immediately signals that no real research went into the meeting.

Investors at LSI are triangulating across dozens of conversations that week. They remember the operators who clearly did the work to be in that specific room, talking to that specific person, more than they remember any single slide.

Real preparation makes the meeting feel like it was built for the person sitting across the table, instead of a script delivered at them.

What This Means for Medtech Founders

Every founder I've watched walk out of LSI with real investor momentum started prepping weeks before the conference, not on the flight there.

Build the target investor list first. Research each fund's stage and portfolio. Script the follow-up sequence before you ever board the plane.

The pitch itself, the part founders spend the most time obsessing over, is the smallest part of the total work.

This is the same discipline behind the market engineering framework every medtech founder should know. The market narrative and the relationship have to exist before the room, whether that room is a Series A meeting or a conference hallway.

LSI just compresses that principle into four days, which is exactly why the operators who prepared ahead of time stand out so clearly against the ones who didn't.

The operators who consistently walk away from LSI with real investor momentum are the ones who did the boring, unglamorous preparation work in the weeks leading up to the conference. Not the ones with the best product on paper.

That's how we approach LSI prep at MarketCraft with the medtech founders we work with. Learning how to prepare for the LSI medtech conference is ultimately about accepting that the conference itself is the smallest part of the process, and putting the disproportionate effort into the setup and the follow-through most founders don't.

Frequently Asked Questions

Why Is LSI Considered the Top Medtech Fundraising Conference?

LSI is considered the top medtech fundraising conference because it concentrates the investors most active in medtech capital raises in one place, over a few days, meeting founders back to back. That concentration makes it the highest-use few days on the fundraising calendar for a well-prepared founder.

How Should Medtech Founders Prepare for LSI?

Medtech founders should prepare for LSI by researching target investors' stage and portfolio in advance, building a follow-up plan before the conference starts, and treating the event as relationship-building rather than a single funding event. Rehearsing pitch delivery out loud matters as much as refining the slides.

Does Attending LSI Guarantee a Medtech Founder Will Get Funded?

Attending LSI does not guarantee funding. The operators who convert LSI meetings into term sheets are the ones who prepared before arriving and followed up methodically afterward, not the ones who relied on the meetings themselves to do the work.

What Should a Founder Do Immediately After an LSI Meeting?

A founder should send a specific, personalized follow-up within a day or two that references what was discussed in the meeting. Generic thank-you notes sent a week later read as an afterthought and cost the momentum built on site.

How Far in Advance Should a Medtech Founder Start Preparing for LSI Europe?

Six to eight weeks minimum. That gives enough time to build the target investor list, research each fund's stage and portfolio, secure warm introductions where possible, and rehearse pitch delivery with a real audience.

Companies that start prep in the week before LSI have already lost the compounding benefit of the setup work.

Listen to the Full Conversations

• Chamath Was Right: Attention Is the Operating System of AI, Media, and Markets
• Cardiac Tech Investor & Board Chairman Ken Nelson
• How Inbrain Neuroelectronics Could Rewire the Brain Using Graphene with Carolina Aguilar
• Medtech Fundraising in 2025: Valuation, Mistakes, and Investor Strategy
• How to Make President's Club in SaaS with Justin Jelley

Subscribe wherever you listen to podcasts.

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, a leading podcast in the medtech industry.

He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.